1)  compatibility
输液配伍
2)  IV medicine incompatibility
输液配伍禁忌
1.
Research on clinical IV medicine incompatibility by pharmacists in PIVAS;
静脉药物配制中心临床输液配伍禁忌的调研
3)  Transfusion
输液
1.
Study on the stability of Danshen injection in two transfusions;
注射用丹参与输液配伍的稳定性考察
2.
Examination of Bacterial Endotoxin in Producing Process of Transfusion;
大输液生产过程细菌内毒素检查与探讨
3.
The Transfusion Effect on Heart Rate Variability of the Senile Hypertensive Patients during Anesthesia;
麻醉中输液量对老年高血压病人心率变异性的影响
4)  Infusion
输液
1.
Study on compatible stability of Sodium aescinate for injection in usual infusion;
注射用七叶皂苷钠在输液中的稳定性研究
2.
Study on compatible stability of Reduced Glutathione for Injection in usual infusions;
注射用还原型谷胱甘肽在输液中的稳定性研究
5)  Infusions
输液
1.
The Stability and Compatibility of Lysinipirin for Injection in Three Different Infusions;
注射用赖氨匹林与三种常用输液的配伍稳定性
2.
The Stability of Compatibility of Fenoldopam Mesylate Injection in Three Different Infusions;
甲磺酸非诺多泮注射液与三种常用输液的配伍稳定性
3.
OBJECTIVE To study the compatible stability of Yinxingdamo injection in five infusions.
目的研究银杏达莫注射液在5种常用输液中的稳定性。
6)  tube for transfusion
输液管
1.
To obtain pyrolysis characteristics of medical waste compositions containing PVC(polyvinyl chloride),thermogravimetric study of tube for transfusion(TFT) and sample collector for urine(SCFU) was carried out using the thermogravimetric analyser(TGA) with N_2.
为研究含聚氯乙烯医疗废物的热解特性,选取输液管和尿样盒为对象,利用差热热重分析仪,在氮气气氛下进行热重实验,探讨了二者热失重行为和机制,分析了反应过程中热量变化及热解剩余物性状,建立了反应动力学模型。
2.
To obtain co-pyrolysis characteristics of medical wastes containing polyvinyl chloride(PVC)and biomass,co-pyrolysis experiments on mixtures of tube for transfusion(TFT)and gauze at different mass proportions,whose main ingredients were PVC and cellulose respectively,were carried out in an atmosphere of N2 using the thermogravimetric analyser(TGA.
为研究聚氯乙烯(polyvinyl chloride,PVC)类与生物质类医疗废物的混合热解特性,利用差热热重分析仪,在氮气气氛下,对输液管(tube for transfusion,TFT;含PVC)和纱布(含纤维素)样品在不同质量配比下进行了混合热解实验,深入研究二者混合热解的行为与规律。
参考词条
补充资料:方剂配伍

方剂配伍

方剂配伍   方剂学术语。方剂是在辨证立法的基础上,按照组方原则,选择适当剂量的药物配伍而成。方剂配伍的原则,是按各药在方中所起的作用,君、臣、佐、使四部分。参见君臣佐使条。

说明:补充资料仅用于学习参考,请勿用于其它任何用途。